Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I E Messinis

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Human Reproduction (Oxford, England)|July 2, 2004
Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological roleK Dafopoulos, C G Kotsovassilis, S Milingos, et al.
The Journal of Endocrinology|October 1, 1994
Circulating gonadotrophin surge-attenuating factor from superovulated women suppresses in vitro gonadotrophin-releasing hormone self-primingP A Fowler, P Cunningham, M Fraser, et al.
Andrologia|March 14, 2014
Sperm DNA fragmentation measured by Halosperm does not impact on embryo quality and ongoing pregnancy rates in IVF/ICSI treatmentsG Anifandis, T Bounartzi, C I Messini, et al.
Journal of Molecular Endocrinology|August 14, 2003
Absence of leptin expression and secretion by human luteinized granulosa cellsM Karamouti, P Kollia, E Karligiotou, et al.
Biomed Research International|July 16, 2014
Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcomeM Dimopoulou, G Anifandis, C I Messini, et al.
Human Reproduction (Oxford, England)|July 23, 2005
Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatmentI E Messinis, D Loutradis, E Domali, et al.
Prenatal Diagnosis|August 24, 2010
Attitudes of pregnant women regarding termination of pregnancy for fetal abnormalityA P Souka, V D Michalitsi, H Skentou, et al.
Clinical Endocrinology|December 18, 2003
FSH and LH responses to GnRH after ovariectomy in postmenopausal womenK C Dafopoulos, C P Kotsovassilis, S D Milingos, et al.
European Journal of Gynaecological Oncology|April 5, 2008
L1 (CAM) (CD171) in ovarian serous neoplasmsA Daponte, E Kostopoulou, P Kollia, et al.
Human Reproduction Update|May 1, 2012
Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysisN P Polyzos, A Zavos, A Valachis, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Human Reproduction (Oxford, England)|July 2, 2004
Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological roleK Dafopoulos, C G Kotsovassilis, S Milingos, et al.
The Journal of Endocrinology|October 1, 1994
Circulating gonadotrophin surge-attenuating factor from superovulated women suppresses in vitro gonadotrophin-releasing hormone self-primingP A Fowler, P Cunningham, M Fraser, et al.
Andrologia|March 14, 2014
Sperm DNA fragmentation measured by Halosperm does not impact on embryo quality and ongoing pregnancy rates in IVF/ICSI treatmentsG Anifandis, T Bounartzi, C I Messini, et al.
Journal of Molecular Endocrinology|August 14, 2003
Absence of leptin expression and secretion by human luteinized granulosa cellsM Karamouti, P Kollia, E Karligiotou, et al.
Biomed Research International|July 16, 2014
Follicular fluid oocyte/cumulus-free DNA concentrations as a potential biomolecular marker of embryo quality and IVF outcomeM Dimopoulou, G Anifandis, C I Messini, et al.
Human Reproduction (Oxford, England)|July 23, 2005
Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatmentI E Messinis, D Loutradis, E Domali, et al.
Prenatal Diagnosis|August 24, 2010
Attitudes of pregnant women regarding termination of pregnancy for fetal abnormalityA P Souka, V D Michalitsi, H Skentou, et al.
Clinical Endocrinology|December 18, 2003
FSH and LH responses to GnRH after ovariectomy in postmenopausal womenK C Dafopoulos, C P Kotsovassilis, S D Milingos, et al.
European Journal of Gynaecological Oncology|April 5, 2008
L1 (CAM) (CD171) in ovarian serous neoplasmsA Daponte, E Kostopoulou, P Kollia, et al.
Human Reproduction Update|May 1, 2012
Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysisN P Polyzos, A Zavos, A Valachis, et al.
Pageof 14